Everything we do is aimed at improving the lives

of the millions of people with nervous system disorders who are in need of new therapeutic options. We never forget that these people may include our own family members or friends, and that these are not just diseases to be treated, but people who need help to make their lives, and those of their loved ones, better.

In this section, you'll meet some of the people at Acorda who are taking new approaches to developing medications that provide hope for people with nervous system disorders – and go beyond the walls of the company to improve lives. You'll also find out how our partnerships and grant program are advancing research and education, and the process for submitting grant requests.

Mission Statement

Acorda's mission is to develop therapies to restore neurological function and improve the lives of people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.

Latest News

May 21, 2013
Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple Sclerosis
May 20, 2013
Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage Strengths